MF
AZN icon

Manchester Financial’s AstraZeneca AZN Stock Holding History

Manchester Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-424
Closed -$42K – 499
2019
Q4 		$42K Buy
+424
New +$39.9K 0.02% 164
2019
Q3 		– Sell
-300
Closed -$25K – 89
2019
Q2 		$25K Buy
+300
New +$23.5K 0.01% 221

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Manchester Financial's AZN Position: Q1 2020 in Review

Manchester Financial sold out of AstraZeneca (AZN) in Q1 2020, closing a stake of 424 shares — an estimated $42K sold.

Manchester Financial first reported a position in AZN in Q2 2019 and held it in 2 quarters. The position peaked at $42K in Q4 2019. 603 funds tracked by Wall St. Rank hold AZN as of Q1 2020.

  • Manchester Financial reported no remaining AstraZeneca position as of Q1 2020 after selling out during the quarter.
  • Manchester Financial sold 424 AstraZeneca shares in Q1 2020, an estimated $42K.
  • Manchester Financial first reported a position in AstraZeneca in Q2 2019 and held it in 2 quarters.
  • Manchester Financial's AstraZeneca position peaked at $42K in Q4 2019.
  • 603 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2020.

Based on Manchester Financial's 13F filing for Q1 2020, filed 20 Apr 2020.